Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Medicine and Dentistry
Adipose Tissue
100%
Lipid Storage
100%
Pericardial Fat
100%
Dapagliflozin
100%
Congestive Heart Failure
54%
Meta-Analysis
9%
Ischemia
9%
Patient with Type 2 Diabetes
9%
Coronary Artery Disease
9%
Echocardiography
9%
Glucagon-Like Peptide-1 Agonist
9%
Image Analysis
9%
Cardiac Magnetic Resonance Imaging
9%
Cardiac Fibrosis
9%
Heart Failure with Reduced Ejection Fraction
9%
Thiazolidinedione
9%
Cotransporter
9%
Comorbidity
9%
Cohort Studies
9%
Nursing and Health Professions
Dapagliflozin
100%
Congestive Heart Failure
85%
Patient with Type 2 Diabetes
14%
Meta Analysis
14%
Coronary Artery Disease
14%
Echocardiography
14%
Sample Size
14%
Cardiovascular Magnetic Resonance
14%
Ischemia
14%
Heart Left Ventricle Mass
14%
Image Analysis
14%
Heart Failure with Reduced Ejection Fraction
14%
Glucagon Like Peptide 1 Receptor Agonist
14%
Cotransporter
14%
Thiazolidinedione
14%
Tissue Characterization
14%
Heart Muscle Fibrosis
14%
Comorbidity
14%
Immunology and Microbiology
Lipid Storage
100%
Adipose Tissue
100%
Pericardial Fat
100%
Magnetic Resonance Imaging
9%
Coronary Artery
9%
Heart Left Ventricle Mass
9%
Agonist
9%
Cotransporter
9%
Sample Size
9%
Tissue Characterization
9%
Comorbidity
9%
Glucagon-Like Peptide-1
9%
Pharmacology, Toxicology and Pharmaceutical Science
Dapagliflozin
100%
Congestive Heart Failure
85%
Cohort Study
14%
Ischemia
14%
Coronary Artery Disease
14%
Glucagon Like Peptide 1 Receptor Agonist
14%
Cotransporter
14%
Thiazolidinedione
14%
Heart Muscle Fibrosis
14%
Heart Failure with Reduced Ejection Fraction
14%
Comorbidity
14%
Maturity Onset Diabetes of the Young
14%
Neuroscience
Adipose Tissue
100%
Dapagliflozin
100%
Meta-Analysis
9%
Cardiac Magnetic Resonance Imaging
9%
Cotransporter
9%
Glucagon-Like Peptide-1 Agonist
9%
Thiazolidinedione
9%
Cardiac Fibrosis
9%
Comorbidity
9%
Ischemia
9%
Keyphrases
Metabolic Organ
10%
Subclinical Stage
10%
Blind Evaluation
10%
Cardiac CT
10%